| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,480 |
6,956 |
$426K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
4,902 |
4,670 |
$363K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
4,911 |
4,760 |
$334K |
| 99000 |
|
5,608 |
5,317 |
$90K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,791 |
2,615 |
$66K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,059 |
1,003 |
$63K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
912 |
882 |
$56K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,584 |
5,347 |
$40K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,739 |
1,824 |
$23K |
| 87428 |
|
690 |
658 |
$22K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,156 |
1,127 |
$14K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,589 |
1,514 |
$14K |
| 87807 |
|
2,041 |
1,947 |
$13K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
192 |
186 |
$3K |
| 81002 |
|
732 |
705 |
$1K |
| 81025 |
|
78 |
74 |
$382.97 |
| CP002 |
|
14 |
12 |
$132.30 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
17 |
17 |
$126.71 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
317 |
306 |
$65.78 |